Kalytera Announces Binding Agreement to Acquire Salzman Group
Hit enter to search or ESC to close
Kalytera Therapeutics, Inc.Kalytera Therapeutics, Inc.Kalytera Therapeutics, Inc.
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact

Press Release Archive

Menu
  • Overview
  • Press Releases
  • Company Information
  • Stock Information
  • Sedar Filings
  • Corporate Governance

Recent Press Releases

December 9, 2015
Kalytera Appoints Dr. Jeff Paley to Board of Directors
December 3, 2015
Kalytera Appoints Ronald P. Erickson to Board of Directors
December 1, 2015
Kalytera Appoints Dr. Jerome Zeldis to Board of Directors
October 12, 2015
Kalytera Appoints Dr. Stuart Silverman, M.D. to Scientific Advisory Board
October 7, 2015
Kalytera Therapeutics and Ramot at Tel Aviv University to Study Bone Healing Properties of Kalytera Drug Candidates; Companies to Pioneer Synthetic CBD Pharma Research

Browse by Year

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Get Email Alerts Subscribe

New Website Coming Soon


© 2020 Kalytera Therapeutics, Inc.

Kalytera Announces Binding Agreement to Acquire Salzman Group
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact

© 2016 Kalytera Therapeutics, Inc.